Literature DB >> 25726048

Demographics, epidemiology, and inheritance of pancreatic ductal adenocarcinoma.

Theresa Pluth Yeo1.   

Abstract

Pancreatic cancer (PC) will affect 48,960 persons in the United States and will result in 40,560 deaths in 2015, according to the American Cancer Society. On a global basis, at least 337,000 persons will be diagnosed with PC. The incidence of PC has increased slightly in the United States, though worldwide cases are likely to increase substantially due to the influence of cigarette smoking, rising obesity and type II diabetes. The development of PC is related to a state of chronic inflammation and insulin resistance. Well-established environmental and personal risk factors for PC include advancing age, cigarette smoking, second-hand tobacco smoke exposure, obesity, inherited familial cancer syndromes, Ashkenazi Jewish heritage, chronic pancreatitis, dietary factors, and diabetes. Other identified associations are human immunodeficiency virus infection, ABO blood group polymorphisms, hepatitis B virus, and Helicobacter pylori.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25726048     DOI: 10.1053/j.seminoncol.2014.12.002

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  46 in total

Review 1.  Biomarkers in pancreatic ductal adenocarcinoma.

Authors:  J Gallego; C López; R Pazo-Cid; F López-Ríos; A Carrato
Journal:  Clin Transl Oncol       Date:  2017-06-14       Impact factor: 3.405

2.  Amplified centrosomes may underlie aggressive disease course in pancreatic ductal adenocarcinoma.

Authors:  Karuna Mittal; Angela Ogden; Michelle D Reid; Padmashree C G Rida; Sooryanarayana Varambally; Ritu Aneja
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

3.  Notch4 inhibition reduces migration and invasion and enhances sensitivity to docetaxel by inhibiting Akt/fascin in pancreatic cancer cells.

Authors:  Cui-Juan Qian; Yi-Yi Chen; Xin Zhang; Fu-Qiang Liu; Ting-Ting Yue; Bei Ye; Jun Yao
Journal:  Oncol Lett       Date:  2016-09-07       Impact factor: 2.967

4.  Mitogen-activated protein kinase inhibition enhances the antitumor effects of sporamin in human pancreatic cancer cells.

Authors:  Cui-Juan Qian; Yong-Xiao Qi; Sheng Zhong; Ju-Ping Zeng; Xiao-Ying Chen; Jun Yao
Journal:  Oncol Lett       Date:  2018-05-18       Impact factor: 2.967

5.  Identification of a pyruvate-to-lactate signature in pancreatic intraductal papillary mucinous neoplasms.

Authors:  Alan R Penheiter; Dinesh K Deelchand; Emily Kittelson; Sibel Erdogan Damgard; Stephen J Murphy; Daniel R O'Brien; William R Bamlet; Marie R Passow; Thomas C Smyrk; Fergus J Couch; George Vasmatzis; John D Port; Małgorzata Marjańska; Stephanie K Carlson
Journal:  Pancreatology       Date:  2017-11-14       Impact factor: 3.996

6.  Total compared with partial pancreatectomy for pancreatic adenocarcinoma: assessment of resection margin, readmission rate, and survival from the U.S. National Cancer Database.

Authors:  M J Passeri; E H Baker; I A Siddiqui; M A Templin; J B Martinie; D Vrochides; D A Iannitti
Journal:  Curr Oncol       Date:  2019-06-01       Impact factor: 3.677

7.  High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.

Authors:  K Allenson; J Castillo; F A San Lucas; G Scelo; D U Kim; V Bernard; G Davis; T Kumar; M Katz; M J Overman; L Foretova; E Fabianova; I Holcatova; V Janout; F Meric-Bernstam; P Gascoyne; I Wistuba; G Varadhachary; P Brennan; S Hanash; D Li; A Maitra; H Alvarez
Journal:  Ann Oncol       Date:  2017-04-01       Impact factor: 32.976

Review 8.  Pancreatic cancer: Are "liquid biopsies" ready for prime-time?

Authors:  Alexandra R Lewis; Juan W Valle; Mairead G McNamara
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

9.  Clinical outcomes of pancreaticoduodenectomy in octogenarians: a surgeon's experience from 2007 to 2015.

Authors:  Diana H Liang; Beverly A Shirkey; Wade R Rosenberg; Sylvia Martinez
Journal:  J Gastrointest Oncol       Date:  2016-08

Review 10.  Nurses' Health Study Contributions on the Epidemiology of Less Common Cancers: Endometrial, Ovarian, Pancreatic, and Hematologic.

Authors:  Brenda M Birmann; Mollie E Barnard; Kimberly A Bertrand; Ying Bao; Marta Crous-Bou; Brian M Wolpin; Immaculata De Vivo; Shelley S Tworoger
Journal:  Am J Public Health       Date:  2016-07-26       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.